Moreover, RNAi-mediated silencing of FGFR3 in IM-resistant GIST cells inhibited their growth, and the combined inhibition of KIT and FGFR3 has a potent synergistic growth-inhibitory effect on IM-resistant GIST cells. Here, FGFR3 is linked to gastrointestinal stromal tumor.